XML 89 R74.htm IDEA: XBRL DOCUMENT v3.26.1
Acquisitions and Related Arrangements - HilleVax Acquisition (Details)
$ / shares in Units, $ in Thousands
1 Months Ended 12 Months Ended
Nov. 01, 2025
Sep. 17, 2025
USD ($)
$ / shares
shares
Aug. 04, 2025
USD ($)
Right
$ / shares
Jul. 31, 2025
Dec. 31, 2025
USD ($)
Aug. 31, 2021
Dec. 31, 2025
USD ($)
Dec. 31, 2024
USD ($)
Aug. 31, 2025
Asset Acquisition                  
Restricted cash         $ 50,802   $ 50,802 $ 4,762  
Operating lease liabilities         22,578   22,578 900  
Lease payments         29,252   29,252    
Contingent value rights liabilities - long-term         10,457   10,457    
Other income, net             $ 12,238 $ 6,921  
Leased facilities, HilleVax - Swiss Lease with lease expiration of September 30, 2026.                  
Asset Acquisition                  
Operating lease liabilities   $ 100              
Subleased facilities, HilleVax Sublease                  
Asset Acquisition                  
Percentage share of security deposit (as a percent)     100.00%            
Sublease expiry term 3 years 2 months                
Subleased facilities, HilleVax Sublease | Within twelve months of the closing date                  
Asset Acquisition                  
Percentage share of sublease (as a percent)             100.00%    
Subleased facilities, HilleVax Sublease | After twelve months of the closing date                  
Asset Acquisition                  
Percentage share of sublease (as a percent)             90.00%    
Subleased facilities, HilleVax Sublease | Restricted cash held for Boston Lease payments                  
Asset Acquisition                  
Restricted cash         40,700   $ 40,700    
HilleVax                  
Asset Acquisition                  
Asset acquisition, share price (in dollars per share) | $ / shares   $ 1.95 $ 1.95            
Number of non-transferable contractual CVR per share | Right     1            
Percentage share of net proceeds from disposition within two years of merger (as a percent)     90.00%            
Percentage share of unused funds in related expense fund at the end of the two-year period (as a percent)     100.00%            
Contingent value right agreement, contingent consideration probable         0   0    
Operating lease liabilities   $ 22,400              
Contingent value rights liability     $ 5,700            
Common stock tendered | shares   50,615,092              
Lease security deposit   $ 1,600              
Sublease Payment   4,100              
Acquired right of use assets, fair value   $ 0              
Contingent value rights liabilities - long-term         700   700    
Other income, net         700        
HilleVax | Restricted Stock Unit Awards                  
Asset Acquisition                  
Asset acquisition, share price (in dollars per share) | $ / shares   $ 1.95              
Total number of underlying shares | shares   137,592              
HilleVax | Leased facilities, HilleVax - Swiss Lease with lease expiration of September 30, 2026.                  
Asset Acquisition                  
Operating lease liabilities   $ 100              
Sublease expiry term       3 years 2 months          
Existence of option to extend           true      
Period of lease extension                 5 years
Lease payments         $ 100   $ 100    
HilleVax | Subleased facilities, HilleVax Sublease                  
Asset Acquisition                  
Percentage share of sublease or security (as a percent)     100.00%